VIDEO: TNF inhibitors improved refractory skin disease in juvenile dermatomyositis

LONDON – Tumor necrosis factor–inhibitor treatment improved refractory skin disease in juvenile dermatomyositis patients in the largest observational study of its kind from the United Kingdom and Ireland Juvenile Dermatomyositis Research Group. Muscle disease in the juvenile dermatomyositis (JDM)...
Source: Skin and Allergy News - Category: Dermatology Source Type: news